2025 ISAKOS Congress in Munich, Germany

2025 ISAKOS Biennial Congress ePoster

 

Endoscopic Calcaneal Speedbridge Technique: Decreased Postoperative Complication Rate In Insertional Achilles Tendinopathy

Ronny Lopes, MD, Lyon FRANCE
Centre Orthopedique Santy, LYON, Sélectionnez, FRANCE

The FDA has not cleared the following pharmaceuticals and/or medical device for the use described in this presentation. The following pharmaceuticals and/or medical device are being discussed for an off-label use:

Summary

This study is the first to investigate outcomes of endoscopic SpeedBridge double-row reinsertion in patients with insertional Achilles tendinopathy. No complications were observed, and functional outcomes were excellent.

ePosters will be available shortly before Congress

Abstract

Background

An endoscopic calcaneal SpeedBridge technique was described recently. The primary objective of this study was to report the post-operative complications seen with calcaneal SpeedBridge repair. The secondary objective was to report short- and medium-term functional outcomes. HYPOTHESIS: Post-operative complications are less common with endoscopic vs. open SpeedBridge suturing. MATERIAL AND METHODS: The endoscopic SpeedBridge technique was used in 9 patients who had insertional Achilles tendinopathy refractory to conservative management. The patients were evaluated at least 24 months after the procedure. Infectious and wound-healing complications were recorded. Visual analogue scale (VAS) scores for pain and patient satisfaction, shoeing difficulties, the European Foot and Ankle Society (EFAS) score, and the Victorian Institute of Sport Assessment-Achilles (VISA-A) score were assessed. RESULTS: During the mean follow-up of 25.3 months, no complications were recorded. The EFAS and VISA-A scores were 37/40 and 91/100, respectively. The mean VAS scores for pain and satisfaction were 1.7/10 and 9.3/10, respectively. No patients reported shoeing difficulties. CONCLUSION: Endoscopic calcaneal SpeedBridge suturing is associated with a lower complication rate compared to the open variant. Clinical outcomes are highly satisfactory in the short and middle terms.